文献速递冠心病

经桡动脉入路与股动脉入路在急性冠脉综合征中的辐射暴露:RAD-Matrix试验

Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial.
PubMed 文献 · J Am Coll Cardiol · 2017-03-18

RAD-MATRIX试验纳入8404例急性冠脉综合征患者,随机分配经桡动脉或股动脉入路行冠脉造影和介入治疗。在18名术者、767例患者中,桡动脉入路术者胸部等效剂量显著高于股动脉入路(77 μSv vs 41 μSv,p=0.02),非劣效性主要终点未达到。总体人群中桡动脉入路透视时间和剂量面积乘积均更高。

要点

  • 桡动脉入路术者胸部等效剂量显著高于股动脉入路(77 μSv vs 41 μSv,p=0.02),非劣效性未达到。
  • 经透视时间或剂量面积乘积归一化后,术者辐射剂量差异仍显著。
  • 总体人群中桡动脉入路透视时间10 min vs 股动脉9 min(p<0.0001),剂量面积乘积65 Gy·cm2 vs 59 Gy·cm2(p=0.0001)。

核心结论

  • 与股动脉入路相比,在当前实践中由经验丰富术者操作时,桡动脉入路与更高的术者和患者辐射暴露相关。
  • 作者建议桡动脉术者和机构应关注辐射风险并采取辅助性辐射防护措施。

研究设计与样本

  • RAD-MATRIX是MATRIX试验的辐射子研究,共8404例伴或不伴ST段抬高型急性冠脉综合征患者随机分配至桡动脉或股动脉入路行冠脉造影和经皮介入治疗。
  • 预设需至少13名术者、每名术者每种入路随机至少13例患者,以确定桡动脉相对于股动脉的非劣效性。
  • 共18名术者完成777例操作、涉及767例患者,术者佩戴胸部(主要终点)、腕部和头部(次要终点)氟化锂热释光剂量计。

主要发现

  • 非劣效性主要终点未达到(非劣效性p=0.843)。
  • 术者胸部等效剂量桡动脉入路77 μSv显著高于股动脉入路41 μSv(p=0.02)。
  • 经透视时间或剂量面积乘积归一化后,术者辐射剂量差异仍显著。
  • 腕部或头部辐射剂量在桡动脉与股动脉入路间无差异。
  • 右桡动脉入路术者胸部剂量84 μSv与左桡动脉入路52 μSv相比无差异(p=0.15)。

关键数值与推荐

  • 总体MATRIX人群中,桡动脉入路透视时间10 min vs 股动脉入路9 min(p<0.0001)。
  • 总体MATRIX人群中,桡动脉入路剂量面积乘积65 Gy·cm2 vs 股动脉入路59 Gy·cm2(p=0.0001)。
  • 术者胸部等效剂量桡动脉入路77 μSv vs 股动脉入路41 μSv(p=0.02)。
  • 非劣效性主要终点p=0.843。

临床怎么用

  • 作者建议桡动脉术者和机构应关注辐射风险并采取辅助性辐射防护措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear whether radial access increases the risk of operator or patient radiation exposure compared to transfemoral access when performed by expert operators. OBJECTIVES: This study sought to determine whether radial access increases radiation exposure. METHODS: A total of 8,404 patients, with or without ST-segment elevation acute coronary syndrome, were randomly assigned to radial or femoral access for coronary angiography and percutaneous intervention, and collected fluoroscopy time and dose-area product (DAP). RAD-MATRIX is a radiation sub-study of the MATRIX (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX) trial. We anticipated that 13 or more operators, each wearing a thorax (primary endpoint), wrist, and head (secondary endpoints) lithium fluoride thermoluminescent dosimeter, and randomizing at least 13 patients per access site, were needed to establish noninferiority of radial versus femoral access. RESULTS: Among 18 operators, performing 777 procedures in 767 patients, the noninferiority primary endpoint was not achieved (p value for noninferiority = 0.843). Operator equivalent dose at the thorax (77 μSv) was significantly higher with radial than femoral access (41 μSv; p = 0.02). After normalization of operator radiation dose by fluoroscopy time or DAP, the difference remained significant. Radiation dose at wrist or head did not differ between radial and femoral access. Thorax operator dose did not differ for right radial (84 μSv) compared to left radial access (52 μSv; p = 0.15). In the overall MATRIX population, fluoroscopy time and DAP were higher with radial compared to femoral access: 10 min versus 9 min (p < 0.0001) and 65 Gy·cm2 versus 59 Gy·cm2 (p = 0.0001), respectively. CONCLUSIONS: Compared to femoral access, radial access is associated with greater operator and patient radiation exposure when performed by expert operators in current practice. Radial operators and institutions should be sensitized towards radiation risks and adopt adjunctive radioprotective measures. (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX; NCT101433627).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sciahbasi A, Frigoli E, Sarandrea A, et al. Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial. J Am Coll Cardiol. 2017. PMID: 28330794. doi:10.1016/j.jacc.2017.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。